Development of fluoroimmunoassays for flecainide

Area of Science:

• Analytical Chemistry
• Biochemistry
• Pharmacology

Background:

• Flecainide acetate is an antiarrhythmic drug requiring therapeutic drug monitoring.
• Accurate measurement of flecainide acetate levels is crucial for patient safety and treatment efficacy.
• Existing methods for flecainide measurement may have limitations in speed, sample compatibility, or sensitivity.

Purpose of the Study:

• To develop and validate simple fluoroimmunoassays for measuring flecainide acetate in biological samples.
• To optimize assays for both rapid therapeutic drug monitoring and sensitive pharmacokinetic studies.
• To provide reliable methods applicable to various sample types and laboratory settings.

Main Methods:

• Development of sheep antibodies against a flecainide:protein conjugate.
• Utilized fluorescein-labeled flecainide for assay development.
• Optimized a rapid, nonseparation fluorescence polarization immunoassay (FPIA).
• Optimized and validated a separation fluoroimmunoassay using magnetizable particles.
• Modified the separation assay for improved sensitivity.

Main Results:

• Successfully developed two distinct fluoroimmunoassay formats for flecainide acetate measurement.
• The nonseparation FPIA was optimized for rapid therapeutic drug monitoring.
• The separation fluoroimmunoassay demonstrated applicability to challenging lipemic, hemolyzed, or icteric samples.
• The separation assay was validated for flecainide therapy monitoring and showed improved sensitivity after modification for pharmacokinetic studies.

Conclusions:

• Fluoroimmunoassays provide a viable and adaptable method for flecainide acetate quantification.
• Both nonseparation and separation assay formats offer advantages for different clinical and research applications.
• These assays facilitate effective therapeutic drug monitoring and pharmacokinetic analysis of flecainide acetate.